Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-22

Clinical Trial Update: Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing lopinavir/ritonavir monotherapy with a regimen of abacavir/lamivudine added to lopinavir/ritonavir in people with lipodystrophy to ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epzicom (abacavir/lamivudine)
  • Kaletra (lopinavir)

Snippet

Sponsor: Fundacion SEIMC-GESIDA | Conditions: HIV Infection, Lipodystrophy | Phase 4 | Status: COMPLETED